Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorThomas, Rhys Hen
dc.contributor.authorZhang, Lin Meien
dc.contributor.authorCarvill, Gemma Len
dc.contributor.authorArcher, John Sen
dc.contributor.authorHeavin, Sinéad Ben
dc.contributor.authorMandelstam, Simone Aen
dc.contributor.authorCraiu, Danaen
dc.contributor.authorBerkovic, Samuel Fen
dc.contributor.authorGill, Deepak Sen
dc.contributor.authorMefford, Heather Cen
dc.contributor.authorScheffer, Ingrid Een
dc.identifier.citationNeurology 2015; 84(9): 951-8en
dc.description.abstractTo delineate the phenotype of early childhood epileptic encephalopathy due to de novo mutations of CHD2, which encodes the chromodomain helicase DNA binding protein 2.We analyzed the medical history, MRI, and video-EEG recordings of 9 individuals with de novo CHD2 mutations and one with a de novo 15q26 deletion encompassing CHD2.Seizures began at a mean of 26 months (12-42) with myoclonic seizures in all 10 cases. Seven exhibited exquisite clinical photosensitivity; 6 self-induced with the television. Absence seizures occurred in 9 patients including typical (4), atypical (2), and absence seizures with eyelid myoclonias (4). Generalized tonic-clonic seizures occurred in 9 of 10 cases with a mean onset of 5.8 years. Convulsive and nonconvulsive status epilepticus were later features (6/10, mean onset 9 years). Tonic (40%) and atonic (30%) seizures also occurred. In 3 cases, an unusual seizure type, the atonic-myoclonic-absence was captured on video. A phenotypic spectrum was identified with 7 cases having moderate to severe intellectual disability and refractory seizures including tonic attacks. Their mean age at onset was 23 months. Three cases had a later age at onset (34 months) with relative preservation of intellect and an initial response to antiepileptic medication.The phenotypic spectrum of CHD2 encephalopathy has distinctive features of myoclonic epilepsy, marked clinical photosensitivity, atonic-myoclonic-absence, and intellectual disability ranging from mild to severe. Recognition of this genetic entity will permit earlier diagnosis and enable the development of targeted therapies.en
dc.titleCHD2 myoclonic encephalopathy is frequently associated with self-induced seizures.en
dc.typeJournal Articleen
dc.identifier.affiliationFrom the Epilepsy Research Centre (R.H.T., L.M.Z., J.S.A., S.B.H., S.A.M., S.F.B., I.E.S.), University of Melbourne, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationDepartment of Neurology (L.M.Z.), Children's Hospital of Fudan University, Shanghai, China; Department of Pediatrics (G.L.C., H.C.M.), Division of Genetic Medicine, University of Washington, Seattle; Florey Institute of Neuroscience and Mental Health (S.A.M., I.E.S.), Melbourne, Australiaen
dc.identifier.affiliationMRC Centre for Neuropsychiatric Genetics & Genomics (R.H.T.), Hadyn Ellis Building, Cathays, Cardiff University, UKen
dc.identifier.affiliationCarol Davila University of Medicine (D.C.), Pediatric Neurology Clinic, Al Obregia Hospital, Bucharest, Romania; and TY Nelson Department of Neurology (D.S.G.), The Children's Hospital at Westmead, Sydney, Australiaen
dc.identifier.affiliationDepartments of Radiology and Paediatrics (S.A.M., I.E.S.), Royal Children's Hospital, and University of Melbourne, Australiaen
dc.contributor.corpauthorEuroEPINOMICS RES Consortiumen
dc.type.austinJournal Articleen, John S
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.languageiso639-1en- Research Centre- Research Centre- Research Centre-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

checked on Feb 21, 2024

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.